Camlin Fine Sciences Limited — Important, 25-02-2025: Updates

Camlin Fine Sciences Limited (CFSL) has entered into an agreement to acquire a majority stake in Vinpai S.A., acquiring approximately 79% of its share capital for €3.60 per share. This strategic acquisition positions CFSL to leverage Vinpai's expertise in natural, algae- and plant-based functional ingredients, which could significantly enhance CFSL's product offerings and global market reach. Alongside the acquisition, CFSL will subscribe to €3.3 million in convertible bonds issued by Vinpai, further supporting its business operations.

After the transaction, CFSL is expected to hold 83.82% of Vinpai, allowing it to take majority control and influence in its operations, which could lead to increased revenues and profitability as Vinpai expands its presence in the food and cosmetics sectors. Investors should watch closely as this move opens new markets and diversification opportunities, although potential dilution from the issuance of new shares as part of this acquisition and bond conversion may impact existing shareholders' positions.